Document:

Fourth Amendment to Employment Agreement

 EXHIBIT 10.2 
  
 FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT 
  
 This Fourth Amendment to Employment Agreement (this “Amendment”) is entered into effective as of
September 20, 2005, by and among SeraCare Life Sciences, Inc., a California corporation (the “Corporation”) and Michael F. Crowley II (“Crowley”). 
  
 WHEREAS, SeraCare, Inc. (the former parent of the Corporation, now known as Biomat USA, Inc.) and Crowley entered into that
certain Employment Agreement, dated November 1, 2000 (as amended by the First Amendment, the Second Amendment and the Third Amendment, the “Employment Agreement”). 
  
 WHEREAS, pursuant to that certain Assignment and Assumption Agreement, dated August 24, 2001, SeraCare, Inc. assigned
its rights and obligations under the Employment Agreement to the Corporation. 
  
 WHEREAS, pursuant to that certain amendment to Employment Agreement, dated November 6, 2001 (the “First Amendment”), the Corporation and Crowley extended the term of the Employment Agreement to
September 25, 2004. 
  
 WHEREAS, pursuant to that certain
second amendment to Employment Agreement, dated June 4, 2003 (the “Second Amendment”), the Corporation and Crowley extended the term of the Employment Agreement to September 25, 2005. 
  
 WHEREAS, pursuant to that certain third amendment to Employment Agreement,
dated November 16, 2004 (the “Third Amendment”), the Corporation and Crowley extended the term of the Employment Agreement to September 25, 2006 and increased Crowley’s annual compensation to $275,000. 
  
 WHEREAS, the Corporation and Crowley wish to amend the Employment Agreement
as provided herein. 
  
 NOW, THEREFORE, in consideration of the
foregoing recitals, the parties hereto, intending to be legally bound, agree as follows: 
  
 1. Amendment to Employment Agreement. 
  
 a. Section 8 of the Employment Agreement is hereby amended by extending the term of the Employment Agreement until September 25, 2007. 

 b. Except as amended by this Amendment, the provisions of the Employment Agreement shall continue for all
purposes without interruption and the Employment Agreement shall remain in full force and effect. 
  
 2. Governing Law. The validity of this Amendment and the interpretation and performance of all of its terms shall be controlled by the substantive
law of California, including California law concerning the interpretation and performance of contracts. 
  
 3. Counterparts. This Amendment may be executed in counterparts, any one of which need not contain the signatures of more than one party, but all
such counterparts when taken together will constitute one and the same instrument. 
  
 IN WITNESS WHEREOF, the undersigned parties have caused this Amendment to be duly executed and delivered as of the date set forth above. 
  

			
	CORPORATION:
	
	SERACARE LIFE SCIENCES, INC.
		
	By:	 	 /s/ Jerry L. Burdick

		
	Name:	 	 Jerry L. Burdick

		
	Title:	 	 Secretary

	 	 	 

  

	
	CROWLEY:
	
	 /s/ Michael F. Crowley, Jr.

	Michael F. Crowley, Jr.Amendment to Consulting Agreement

 EXHIBIT 10.3 
  
 AMENDMENT TO CONSULTING AGREEMENT 
  
 This Amendment to Consulting Agreement (this “Amendment”), dated September 20, 2005, is made and entered into
by and among SeraCare Life Sciences, Inc., a California corporation (the “Corporation”) and Burdick Management, Inc. (“Consultant”). 
  
 WHEREAS, the Corporation and Consultant entered into that certain Consulting Agreement, dated August 19, 2004 (the “Consulting
Agreement”). 
  
 WHEREAS, pursuant to the terms of the
Consulting Agreement, Consultant has designated Jerry L. Burdick as the operative consultant under the Consulting Agreement. 
  
 WHEREAS, the parties desire to amend the Consulting Agreement to (i) extend its term by one year and (ii) increase the hourly consulting
fee to be paid to Consultant from $50 per hour to $100 per hour. 
  
 NOW, THEREFORE, in consideration of the foregoing recitals, the parties hereto, intending to be legally bound, agree as follows: 
  
 1. Amendments to Consulting Agreement. 
  
 a. Section III of the Consulting Agreement is hereby amended by increasing the hourly rate to be paid by the Corporation to Consultant from $50 per
hour to $100 per hour. 
  
 b. Sections I, IV.C.2 and XI.B
are hereby amended by replacing the date “August 31, 2006” with the date “August 31, 2007” in each such section. 
  
 c. Except as amended by this Amendment, the provisions of the Consulting Agreement shall continue for all purposes without interruption and the
Consulting Agreement shall remain in full force and effect. 
  
 2. Governing Law. The validity of this Amendment and the interpretation and performance of all of its terms shall be controlled by the substantive law of California, including California law concerning the interpretation and
performance of contracts. 
  
 3. Counterparts. This
Amendment may be executed in counterparts, any one of which need not contain the signatures of more than one party, but all such counterparts when taken together will constitute one and the same instrument. 
  
 IN WITNESS WHEREOF, the undersigned parties have caused this Amendment
to be duly executed and delivered as of the date set forth above. 
  

									
	CORPORATION:	 	 	 	CONSULTANT:
			
	SERACARE LIFE SCIENCES, INC.	 	 	 	BURDICK MANAGEMENT, INC.
					
	By:	 	 /s/ Michael Crowley, Jr.
	 	 	 	By:	 	 /s/ Jerry L. Burdick

	 	 	 Michael Crowley, Jr.
 President and Chief Executive
Officer
	 	 	 	 	 	 Jerry L. Burdick
 PresidentFiscal 2006 Director Compensation Plan

 EXHIBIT 10.4 
  
 SERACARE LIFE SCIENCES, INC. 
 Fiscal 2006 Director Compensation Plan 
  
 Board of Director Compensation 
  

	 	•	 	All Board members (other than Mr. Crowley) shall receive a cash fee of $10,000, to be paid at such time and in such installments during fiscal 2006 as may be determined by the
Board 

  

	 	•	 	All Board members (other than Mr. Crowley and Mr. Plost) shall receive a fully vested five-year option to purchase 15,000 shares of the Company’s common stock at an
exercise price equal to the closing price of the Company’s common stock on the date of the grant, such grant to be made at such time as may be determined by the Board 

  

	 	•	 	For serving as Chairman of the Board of Directors, Mr. Plost shall receive a fully vested five-year option to purchase 25,000 shares of Company Common Stock at an exercise
price equal to the closing price of the Company’s common stock on the date of the grant, such grant to be made at such time as may be determined by the Board 

  

	 	•	 	All Board members shall be reimbursed for their expenses in serving as Board members and shall also be paid a cash fee of $1,500 for each meeting attended in person and a cash fee
of $500 for each meeting attended telephonically 

  
 Audit Committee Compensation 
  

	 	•	 	All Audit Committee members other than Mr. Cresci shall receive (a) a cash fee of $2,500, to be paid at such time and in such installments during fiscal 2006 as may be
determined by the Board and (b) a fully vested five-year option to purchase 2,500 shares of the Company’s common stock at an exercise price equal to the closing price of the Company’s common stock on the date of the grant, such grant
to be made at such time as may be determined by the Board 

  

	 	•	 	For serving as Chairman of the Audit Committee, Mr. Cresci shall receive (a) a cash fee of $7,500, to be paid at such time and in such installments during fiscal 2006 as
may be determined by the Board and (b) a fully vested five-year option to purchase 5,000 shares of the Company’s common stock at an exercise price equal to the closing price of the Company’s common stock on the date of the grant, such
grant to be made at such time as may be determined by the Board 

  

	 	•	 	Mr. Cresci shall also be paid a cash fee of $1,000 for each Audit Committee meeting attended in person and a cash fee of $500 for each Audit Committee meeting attended
telephonically 

  

	 	•	 	All Audit Committee members shall be reimbursed for their expenses in serving as Audit Committee members 

  
 Compensation Committee Compensation 
  

	 	•	 	All Compensation Committee members other than Mr. Anderson shall receive a cash fee $2,500, to be paid at such time and in such installments during fiscal 2006 as may be
determined by the Board 

  

	 	•	 	For serving as Chairman of the Compensation Committee, Mr. Anderson shall be paid a cash fee of $5,000, to be paid at such time and in such installments during fiscal 2006 as
may be determined by the Board 

  

	 	•	 	All Compensation Committee members shall be reimbursed for their expenses in serving as Compensation Committee membersSummary of Non-Employee Director Compensation

 Exhibit 10.1 
  
 Summary of Non-Employee Director Compensation 
  
 Each non-employee director receives an annual retainer of $140,000, consisting of a cash and a restricted stock component,
plus certain other fees as described below: 
  

	 	•	 	Each non-employee director receives an annual cash retainer of $60,000. 

  

	 	•	 	The chair of each Board committee (other than the Audit Committee) receives an additional annual cash retainer of $5,000. The chair of the Audit Committee receives an additional
annual cash retainer of $10,000. 

  

	 	•	 	Non-employee directors also receive a fee of $1,500 for attendance at each meeting of the Board and each committee meeting, other than telephonic meetings, for which the fee is
$500. Pursuant to the Company’s Deferred Compensation Plan, directors may defer receipt of their annual retainer and/or meeting fees until retirement from the Board. 

  

	 	•	 	Non-employee directors also receive an annual grant of $80,000 of Raytheon common stock. Grants are made under the 1997 Nonemployee Directors Restricted Stock Plan. All grants
consist of restricted stock and are held in the custody of the Company until restrictions lapse, generally on the date of the annual meeting one year after the award. The directors receive dividends on these shares and are entitled to vote these
shares. 

  

	 	•	 	The Company reimburses directors for actual expenses incurred in the performance of their service as directors, including attendance at director education programs sponsored by
educational and other institutions. The Company also reimburses directors for the costs of their spouses to travel with them to Company-sponsored business events. The Company also maintains a general insurance policy which provides non-employee
directors with up to $100,000 per incident in travel accident insurance when on Company business. 

  
 The lead director receives an additional annual retainer of $60,000, payable as follows: $24,000 in cash and an annual grant of $36,000 of restricted
shares of Raytheon common stock. 
  
 September 22, 2005

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00091-of-00352.parquet"}]]